Researchers from Niigata University and a University of Pennsylvania team have identified a novel macrolide–DEL-1 axis that helps in bone regeneration and new bone formation. This finding may lead to the development of therapeutic agents to treat bone loss disorders. The study is published in the journal iScience.
You may also be interested in:
Babies who are breastfed, or partially breastfed, for more than six months are less likely to be given sugar-sweetened drinks and sweet or salty snacks [...]
Increased numbers of preterm births, higher incidence of respiratory disease and death, and more children in hospitals are some of the stark health outcomes the [...]
After a one-year interdisciplinary therapy program that included clinical, nutritional, psychological and exercise counseling, a group of 22 obese adolescents not only lost weight but [...]